Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • PDD vs MRNA✓SelectedUSD · MRNAPDD vs MRNA performance historyLatest closeAs of+1.86%11/13
Stock and ETF performance explorer

PDD vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-27.7%
MRNA return
+221.0%
Excess return
-248.7%
Maximum drawdown
-53.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D+1.9%-3.4%+5.3%+2.0%
7D-4.9%-12.1%+7.2%-4.4%
30D-3.0%-1.3%-1.8%-3.2%
3M-6.2%+250.9%-257.1%-14.2%
6M-20.7%+343.0%-363.7%-29.8%
YTD-30.4%+657.4%-687.8%-43.0%
1Y-41.3%+794.9%-836.2%-53.2%
3Y-27.7%+218.1%-245.8%-34.0%
All-27.7%+221.0%-248.7%-34.0%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling